Investigating Modes of Progressive Mobility
Critical Care, Mechanical Ventilation, Intensive Care
About this trial
This is an interventional treatment trial for Critical Care focused on measuring therapeutic mobility, acute care, nursing, inflammatory markers
Eligibility Criteria
Inclusion Criteria:
- P:F ratio > 100
- FiO2 < 60% and PEEP less than 10 cmH20
- hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline)
- baseline (rest) vitals signs of HR 50-110
- mean arterial pressure (MAP) 60-100 mmHg
- peripheral oxygenation saturation (SpO2) greater than 88%
- Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement
- a high degree of dependency on others for positioning is acceptable
- there are no exclusions based on gender or minority status.
Exclusion Criteria:
- End-stage muscular dystrophy
- myasthenia gravis
- new quadriplegia
- coma
- increased intracranial pressure
- unrepaired hip fracture and multiple lower extremity fractures
- Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded
- concurrent use of a continuous lateral rotation bed
- patients for high risk of death will also be excluded
- MICU admission following a hospital stay of >9 days in the past months
- age >80 in the presence of 2 or more life-threatening illnesses
- diagnosis of an active stage IV malignancy
- status post cardiac arrest
- diagnosis of intracerebral hemorrhage requiring mechanical ventilation
- subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
1
2
RA begins data collection with chart review for demographic and explanatory variables, collects data for baseline muscle strength. During standard care period, PM will obtain information about the plan for activity for enrolled patients (turning, complete or partial weight-bearing i.e., reverse Trendelenberg positioning, ROM, sitting and walking) through discussion with the direct providers. RA will interview one provider about factors which influence the decision to implement activity or provide bedrest, including the presence of orders for bedrest or physical therapy. If activity is planned, the PM will observe and record the type and duration of activity, drawing serum biomarkers 20 minutes before and 20 minutes after the activity. If no activity is planned or activity duration is less than 10 minutes, serum for only baseline inflammatory biomarkers will be drawn. The RA will collect outcomes data within 24 hours of discharge from the ICU.
Identical procedures for date recruitment, consent and data collection will occur. In this phase, the Project Manager will promote the use of the ETM protocol through coaching (e.g., reminding staff of benefits of mobility, identification of available resources, or suggesting cessation of bedrest orders) and by participating in planning at least one 20-minute activity.